MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
RNAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cartesian Therapeutics (RNAC) Ownership - Who owns Cartesian Therapeutics?

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
7495 New Horizon Way
Phone
+1 301 348-8698
Employees
75
Web
https://www.cartesiantherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
172.18M
P/E Ratio
1.98
Total Cash
118.64M
Projected Growth
N/A
Total Debt
11.86M
Revenue
1.78M
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
4.04
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RNAC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for RNAC
A.I. Advisor
published General Information

General Information

a developer of targeted immunotherapies and vaccines to treat and prevent diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
7495 New Horizon Way
Phone
+1 301 348-8698
Employees
75
Web
https://www.cartesiantherapeutics.com